Genetics of polycystic ovary syndrome

Molecular and Cellular Endocrinology

Volumn 145, Issue 1-2, 1998, Pages 123-128

  Franks, Stephen ^a   Gharani, Neda ^a   Waterworth, Dawn ^a,b   Batty, Sari ^a   White, Davinia ^a   Williamson, Robert ^a   McCarthy, Mark ^a  

^a IMPERIAL COLLEGE SCHOOL OF MEDICINE   (United Kingdom)

^b ROYAL FREE AND UNIVERSITY COLLEGE MEDICAL SCHOOL   (United Kingdom)

Author keywords

Insulin; Polycystic ovary syndrome; Theca cells

Indexed keywords

ANDROGEN SYNTHESIS; CONFERENCE PAPER; GENE LOCUS; GENETIC POLYMORPHISM; HUMAN; INSULIN RELEASE; OVARY POLYCYSTIC DISEASE; PRIORITY JOURNAL; THECA CELL;

EID: 0032566951     PISSN: 03037207     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0303-7207(98)00178-6     Document Type: Conference Paper

References (51)

1. Adams J., Polson D.W., Franks S. Prevalence of polycystic ovaries in women with anovulation and idiopathic hirsutism. Br. Med. J. 293:1986;355-359.
2. Barnes R.B., Rosenfield R.L., Burstein S., Ehrmann D.A. Pituitary-ovarian responses to nafarelin testing in the polycystic ovary syndrome. N. Engl. J. Med. 320:1989;559-565.
3. Bennett S.T., Lucassen A.M., Gough S.C.L. et al. Susceptibility to human type 1 diabetes at IDDM2 is determined by tandem repeat variation at the insulin gene minisatellite locus. Nat. Genet. 9:1995;284-292.
4. Bennett S.T., Todd J.A. Human type 1 diabetes and the insulin gene: principles of mapping polygenes. Annu. Rev. Genet. 30:1996;343-370.
5. Bennett S.T., Todd J.A., Waterworth D.M., Franks S., McCarthy M. Association of the insulin gene VNTR with polycystic ovary syndrome (letter). Lancet. 349:1997;1771-1772.
6. Carey A.H., Waterworth D., Patel K., White D., Little J., Novelli P., Franks S., Williamson R. Polycystic ovaries and premature male pattern baldness are associated with one allele of the steroid metabolism gene CYP17. Hum. Mol. Genet. 3:1994;1873-1876.
7. Carey A.H., Chan K.L., Short F., White D.M., Williamson R., Franks S. Evidence for a single gene effect in polycystic ovaries and male pattern baldness. Clin. Endocrinol. 38:1993;653-658.
8. Clayton R.C., Ogden V., Hodgkinson J. et al. How common are polycystic ovaries in normal women and what is their significance for fertility in the general population? Clin. Endocrinol. 37:1992;127-134.
9. Conway G.S., Honour J.W., Jacobs H.S. Heterogeneity of the polycystic ovary syndrome: clinical endocrine and ultrasound features in 556 patients. Clin. Endocrinol. 30:1989;459-467.
10. Cooper H., Spellacy W., Prem K., Cohen W. Hereditary factors in the Stein-Leventhal syndrome. Am. J. Obstet. Gynecol. 100:1968;371-387.
11. Dahlgren E., Johannson S., Lindstedt G et al. Women with polycystic ovary syndrome wedge resected in 1956 to 1965: a long term follow up focusing on natural history and circulating hormones. Fertil. Steril. 57:1992;505-513.
12. Dahlgren E., Janson P.O., Johansson S. et al. Polycystic ovary syndrome and risk for myocardial infarction: evaluated from a risk factor model based on a prospective study of women. Acta Obstet. Gynecol. Scand. 71:1992;599-604.
13. Dunaif A., Graf M., Mandeli J., Laumas V., Dobrjansky A. Characterization of groups of hyperandrogenic women with acanthosis nigricans, impaired glucose tolerance, and/or hyperinsulinemia. J. Clin. Endocrinol. Metab. 65:1987;499-507.
14. Dunaif A., Xia J., Book C.-B., Schenker E., Tang Z. Excessive insulin receptor phosphorylation in cultured fibroblasts and in skeletal muscle. J. Clin. Invest. 96:1995;801-810.
15. Dunaif A., Finegood D.T. β Cell dysfunction independent of obesity in the polycystic ovary syndrome. J. Clin. Endocrinol. Metab. 81:1996;942-947.
16. Dunaif A. Insulin resistance and the polycystic ovary syndrome: mechanism and implications for pathogenesis. Endocr. Rev. 18:1997;774-800.
17. Ehrmann D., Sturis J., Byrne M., Karrison T., Rosenfield R., Polonsky K. Insulin secretory defects in polycystic ovary syndrome: relationship to insulin sensitivity and family history of non-insulin-dependent diabetes mellitus. J. Clin. Invest. 96:1995;520-527.
18. Ferriman D., Purdie A.W. The inheritance of polycystic ovarian disease and a possible relationship to premature balding. Clin. Endocrinol. 11:1979;291-300.
19. Franks S. Polycystic ovary syndrome: a changing perspective. Clin. Endocrinol. 31:1989;87-120.
20. Franks S. The ubiquitous polycystic ovary. J. Endocrinol. 129:1991;317-319.
21. Franks S. Medical progress article: polycystic ovary syndrome. N. Engl. J. Med. 333:1995;853-861.
22. Franks, S., Willis, D., Mason, H., Gilling-Smith, C., 1996. Comparative androgen production from theca cells of normal women and women with polycystic ovaries. In: Chang, R.J. (Ed.), Polycystic Ovary Syndrome, Springer, New York, pp. 154-164.
23. Franks S. The 17α-hydroxylase-17, 20-lyase gene (CYP17) and polycystic ovary syndrome (commentary). Clin. Endocrinol. 46:1997;135-136.
24. Gharani N., Waterworth D.M., Williamson R., Franks S. 5′ polymorphism of the CYP17 gene is not associated with serum testosterone levels in women with polycystic ovaries (letter). J. Clin. Endocrinol. Metab. 81:1996;4174.
25. Gharani N., Waterworth D.M., Batty S., White D., Gilling-Smith C., Conway G.S., McCarthy M., Franks S., Williamson R. Association of the steroid synthesis gene CYP11a with polycystic ovary syndrome and hyperandrogenism. Hum. Mol. Genet. 6:1997;397-402.
26. Gilling-Smith C., Willis D.S., Beard R.W., Franks S. Hypersecretion of androstenedione by isolated theca cells from polycystic ovaries. J. Clin. Endocrinol. Metab. 79:1994;1158-1165.
27. Gilling-Smith C., Story E.H., Franks S. Evidence for a primary abnormality of thecal cell steroidogenesis in the polycystic ovary syndrome. Clin. Endocrinol. 47:1997;93-99.
28. Givens J.R. Familial polycystic ovarian disease. Endocrinol. Metab. Clin. N. Am. 17:1988;771-783.
29. Hague W.M., Adams J., Reeders S.T., Peto T.E., Jacobs H.S. Familial polycystic ovaries: a genetic disease? Clin. Endocrinol. 29:1988;593-605.
30. Holte J., Bergh T., Berne C., Berglund L., Lithell H. Enhanced early insulin response to glucose in relation to insulin resistance in women with polycystic ovary syndrome and normal glucose tolerance. J. Clin. Endocrinol. Metab. 78:1994;1052-1058.
31. Holte J., Bergh T., Berne C. et al. Restored insulin sensitivity but persistently increased early insulin secretion after weight loss in obese women with polycystic ovary syndrome. J. Clin. Endocrinol. Metab. 80:1995;2586-2593.
32. Holte J. Disturbances in insulin secretion and sensitivity in women with the polycystic ovary syndrome. Bailliere's Clin. Endocrinol. Metab. 10:1996;221-247.
33. Hull M.G. Epidemiology of infertility and polycystic ovarian disease: endocrinological and demographic studies. Gynecol. Endocrinol. 1:1987;235-245.
34. Ibanez L., Hall J.E., Potau N., Carrascosa A., Prat A., Taylor A.E. Ovarian 17-hydroxyprogesterone hyperresponsiveness to gonadotropin-releasing hormone (GnRH) agonist challenge in women with polycystic ovary syndrome is not mediated by luteinizing hormone hypersecretion: evidence from GnRH agonist and human chorionic gonadotropin stimulation testing. J. Clin. Endocrinol. Metab. 81:1996;4103-4107.
35. Kruglyak L., Daly M.J., Reeve-Daly M.P. et al. Parametric and non-parametric linkage analysis: a unified multipoint approach. Am. J. Hum. Genet. 58:1996;1347-1363.
36. Legro R.S. The genetics of polycystic ovary syndrome. Am. J. Med. 98. 1A:1995;9-16.
37. Lunde O., Magnus P., Sandvik L., Hoglo S. Familial clustering in the polycystic ovarian syndrome. Gynecol. Obstet. Invest. 28:1989;23-30.
38. Moller D.E., Flier J.S. Detection of an alteration in the insulin receptor gene in a patient with insulin resistance, acanthosis nigricans and the polycystic ovary syndrome. N. Engl. J. Med. 319:1988;1526-1529.
39. O'Meara N., Blackman J.D., Ehrmann D.A. et al. Defects in B-cell function in functional ovarian hyperandrogenism. J. Clin. Endocrinol. Metab. 76:1993;1241-1247.
40. O'Driscoll J.B, Mamtora H., Higginson J., Pollock A., Kane J., Anderson D.C. A prospective study of the incidence of clear-cut endocrine disorders and polycystic ovaries in 350 patients with hirsutism or androgenic alopecia. Clin. Endocrinol. 41:1994;231-236.
41. Polson D.W., Adams J., Wadsworth J., Franks S. Polycystic ovaries - a common finding in normal women. Lancet. 1(8590):1988;870-872.
42. Pugeat, M., Nicolas, M.H., Cousin, P., Mirakian, P., Brebant, Ch., Dechaud, H., Lejeune, H., Forest, M.G. , 1996. Polymorphism in the 5′ promoter of the human gene encoding P450c17α and adrenal androgen secretion in hirsute women. Programme of the Tenth International Congress of Endocrinology, San Francisco, June 1996, The Endocrine Society: abstract P2-626.
43. Robinson S., Kiddy D., Gelding S.V., Willis D., Niththyananthan R., Bush A., Johnston D.G., Franks S. The relationship of insulin sensitivity to menstrual pattern in women with hyperandrogenism and polycystic ovaries. Clin. Endocrinol. 39:1993;351-355.
44. Rosenfield R.L., Barnes R.B., Cara J.F., Lucky A.W. Dysregulation of cytochrome P450c 17 alpha as the cause of polycystic ovarian syndrome. Fertil. Steril. 53:1990;785-791.
45. Simpson, J.L., 1992. Elucidating the genetics of polycystic ovary syndrome. In: Dunaif, A, Givens, J.R., Haseltine, F.P., Merriam, G.R. (Eds.), Polycystic ovary syndrome. Blackwell, Oxford, pp. 59-77.
46. Spielman R.S., Ewens W.J. The TDT and other family-based tests for linkage disequilibrium and association. Am. J. Hum. Genet. 59:1996;983-989.
47. Talbot J.A., Bicknell E.J., Rajkhowa M., Krook A., O'Rahilly S., Clayton R.N. Molecular scanning of the insulin receptor gene in women with polycystic ovary syndrome. J. Clin. Endocrinol. Metab. 81:1996;1979-1983.
48. Tetchatraisak K., Conway G.S., Rumsby G. Frequency of a polymorphism in the regulatory region of the 17α-hydroxylase-17,20 lyase (CYP17) gene in hyperandrogenic states. Clin. Endocrinol. 46:1997;131-134.
49. Waterworth D.M., Bennett S.T., Gharani N. et al. Linkage and association of insulin gene VNTR regulatory polymorphism with polycystic ovary syndrome. Lancet. 349:1997;986-989.
50. Weaver J.U., Kopelman P.G., Hitman G.A. Central obesity and hyperinsulinaemia in women are associated with polymorphism in the 5′ flanking region of the human insulin gene. Eur. J. Clin. Invest. 22:1992;265-270.
51. Zawadzki, J.K., Dunaif, A., 1992. Diagnostic criteria for polycystic ovary syndrome: towards a rational approach. In: Dunaif, A., Givens, J.R., Haseltine, F.P., Merriam, G.R. (Eds.), Polycystic ovary syndrome. Blackwell, Oxford, pp. 377-384.